Pharm110 Chp 19 Anticoagulants, antiplatelets, Thrombolytics Flashcards
Anticoagulants
Heparin (subcut or IV)
Dalteparin, enoxaparin (low molecular weight, admind subcut)
Warfarin (oral)
- Prevent formation of a thrombus (blood clot)
- No direct effect on existing thrombus, do not reverse any damage from thrombus.
- Prevent additional clots from forming
- Commonly called blood thinners by patients
Uses of anticoagulants
- Prophylaxis and treatment of DVT
- Prevent and treat atrial fibrillation with embolization
- Prevention and treatment of PE (pulmonary embolism)
- Adjuvent treatment of MI
- Prevent of postoperative DVT and PE in surgical patients.
Anticoagulant warnings
Contraindicated in patients with
- Severe renal or hepatic disease
- Active bleeding
- GI ulcers
- Recent eye or CNS surgery
- Pregnancy(can cause fetal death) and lactation
Anticoagulants Thrombolytic nursing implications
- Before administering first dose question patient about all drugs taken during the previous 2 to 3 weeks or if Pt. was recently hospitalized.
- If patient took any drugs, before admin, nurse notifies Dr.
Heparin action
- Indirectly interferes with conversion of prothrombin to thrombin
- Deficiency of thrombin prevents the conversion of fibrinogen to fibrin, which prevents clot formation.
- Admin IV, do not give orally or IM
- Admin subcut (Longer acting form)
- No IM for risk of excessive bleeding
Heparin admin do’s and don’ts
- Prefilled syringes, Do not expel air bubble
- Pinch fold in skin to for deep subcut admin
- 90 degree inject
- Do not aspirate
- Monitor aPTT (activated partial thromboplastin time) when admining heparin)
- Normal aPTT is 30-40 seconds (patients on heparin should have aPTT 1.5-2.5 times normal
- Contact Dr. if aPTT is not 1.5-2.5 times normal.
Heparin adverse effects
-Hemorrhage
-Allergy
Antidote Protamine sulfate
Do not administer to clients with coagulation disorders e.g. hemophilia, Von Willebrand disease.
Low Molecular weight heparins
Related to heparin
-Minor risk for bleeding
Does not affect action of thrombin in clotting cascade
Have little effect on the aPTT values
e.g. Enoxaparin, Dalteparin
Warfarin
Only oral anticoagulant (used as rat poison)
- Inhibits blood clotting by interfering with the synthesis of vitamin K dependant clotting factors (II, VII, IX, and X) in the liver-The prothrombin time (PT) and international normalized ration (INR) is determined before therapy begins.
- The 1st dose of Warfarin is not given until the blood is drawn for baseline PT/INR test.
- Dosage is Individualized based on the results of the PT or the INR.
- Orals are most often used for long term therapy
- INR is maintained between 2 and 3
- The PT is kept between 25-30 seconds.
-Nurse withoholds drug and notifies Dr. if the INR exceeds the prescribed level or the PT exceeds 30 seconds.
Bleeding risk
Bleeding can occur ANY time during Warfarin therapy, even with INR is within safe limits.
Warfarin overdose symptoms
- Blood in stool (melena)
- Petechiae (pin point sized red dots on skin)
- Bleeding gums after brushing teeth
- Bleeding cuts from shaving
- Excessive menstrual bleeding
Warfarin nursing implications
Immediately report to Dr. any of the adverse effects or bleeding.
- Discontinue drug use for a few days or order Vitamin K (phytonadione) an oral anticoagulant antagonist.
- Vitamin K reverses Warfarin effects by providing necessary ingredient to enhance clot formation and stop bleeding.
Warfarin patient and family teaching
- Keep all Dr and lab appointments
- Take drug at same time each day
- Avoid alcohol
- Maintain a consistent daily intake of vitamin K to help maintain a consistent INR value
- Avoid the use of aspirin and NDSAIDs
- Any evidence of bleeding notify Dr right away
- Use soft toothbrush and electric razor
- Women of childbearing age should use a reliable contraceptive to avoid pregnancy
Antiplatelet agents
Inhibit the aggregation of platelets
-Treat patients who have had cerebrovascular accidents or myocardial infarctions
e.g. Acetylsalicylic acid (Aspirin)
Abciximab (ReoPro)
Clopidogrel bisulfate (Plavix)
Thrombolytic agents
Enzymes that convert plasminogen to the enzyme fibrinolysin
- Only administered IV, they dissolve (lyse) potentially fatal blood clots.
- Given to pts. with AMI, ischemic stroke, pulmonary embolism, DVT.
e.g. Alteplase-recombinant (Activase)
Thrombolytic for AMI
- Pt should receive drug within 12 hours after heart attack starts.
- Ideally pt. should receive drug within the first 90 minutes after arriving at the hospital
- Pt. may need PTCA or CABG even after administration